CoreFirst Bank & Trust’s Gilead Sciences GILD Stock Holding History

CoreFirst Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-900	Closed	-$99.9K	–	316
2025 Q3	$99.9K	Hold	900	–	–	0.05%	166
2025 Q2	$99.8K	Buy	+900	New	+$95.8K	0.06%	160
2025 Q1	–	Sell	-900	Closed	-$83.1K	–	199
2024 Q4	$83.1K	Sell	900 -330	-27%	-$29.7K	0.05%	171
2024 Q3	$103K	Buy	+1,230	New	+$93.9K	0.06%	158
2024 Q2	–	Sell	-1,590	Closed	-$116K	–	210
2024 Q1	$116K	Sell	1,590 -100	-6%	-$7.69K	0.07%	159
2023 Q4	$137K	Sell	1,690 -230	-12%	-$17.9K	0.09%	145
2023 Q3	$144K	Hold	1,920	–	–	0.1%	142
2023 Q2	$148K	Hold	1,920	–	–	0.1%	142
2023 Q1	$159K	Hold	1,920	–	–	0.12%	141
2022 Q4	$165K	Sell	1,920 -72	-4%	-$5.7K	0.13%	144
2022 Q3	$123K	Hold	1,992	–	–	0.11%	148
2022 Q2	$123K	Sell	1,992 -877	-31%	-$54.3K	0.1%	151
2022 Q1	$171K	Sell	2,869 -330	-10%	-$21.1K	0.12%	141
2021 Q4	$232K	Hold	3,199	–	–	0.15%	124
2021 Q3	$223K	Hold	3,199	–	–	0.15%	124
2021 Q2	$220K	Hold	3,199	–	–	0.15%	132
2021 Q1	$207K	Hold	3,199	–	–	0.14%	132
2020 Q4	$186K	Buy	+3,199	New	+$193K	0.14%	133

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CoreFirst Bank & Trust's GILD Position: Q4 2025 in Review

CoreFirst Bank & Trust sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 900 shares — an estimated $99.9K sold.

CoreFirst Bank & Trust first reported a position in GILD in Q4 2020 and held it in 18 quarters. The position peaked at $232K in Q4 2021. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

CoreFirst Bank & Trust reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
CoreFirst Bank & Trust sold 900 Gilead Sciences shares in Q4 2025, an estimated $99.9K.
CoreFirst Bank & Trust first reported a position in Gilead Sciences in Q4 2020 and held it in 18 quarters.
CoreFirst Bank & Trust's Gilead Sciences position peaked at $232K in Q4 2021.
2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on CoreFirst Bank & Trust's 13F filing for Q4 2025, filed 11 Feb 2026.